$PEAR Goes Public in $1.6B SPAC Deal
Pear Therapeutics, a SoftBank-backed healthcare startup has agreed to go public through a merger with Thimble Point Acquisition Corp, a blank cheque company affiliated with an heir of the Pritzker family, creating a business valued at $1.6 billion.
Read more